Chronic Wound Care Market size is anticipated to reach USD 20 billion by the end of 2033, growing at a CAGR of 10% during the forecast period, i.e., 2023-2033. In the year 2022, the industry size of chronic wound care was over USD 10 billion. The growth of the market can primarily be ascribed to the worldwide upsurge in chronic wound cases, owing to accidents, injuries, and fatalities. Furthermore, there has been an increase in the number of accident cases across the globe, that is raising the demand for chronic wound care. Hence, these rising wound cases are expected to increase the utilization rate of chronic wound care which in turn, is projected to expand the global chronic wound care market. As per the reported data, more than 2% to 4% population of developed nations around the globe suffer from chronic wounds.
Moreover, high prevalence of chronic diseases such as autoimmune diseases, diabetes, and others is projected to boost the growth of the global chronic wound care market. According to the data reported, six in ten Americans in the United States live with at least one chronic disease. Moreover, these wounds require significant medical treatment as well as effective wound care supplies. In addition, there has been an increase in expenses for wound and patient care. It was observed in a clinical study that, P. aeruginosa and S. aureus are two of the bacteria which are most frequently found in infections of chronic wounds. Furthermore, when P. aeruginosa and S. aureus are cultivated together in a wound model, they have relatively high antibiotic resistance.
Growth Drivers
Challenges
|
Base Year |
2022 |
|
Forecast Year |
2023-2033 |
|
CAGR |
~10% |
|
Base Year Market Size (2022) |
~ USD 10.0 billion |
|
Forecast Year Market Size (2033) |
~ USD 20.0 billion |
|
Regional Scope |
|
End-user (Hospitals, Homecare Settings, Ambulatory Centers, Wound Care Centers)
The global chronic wound care market is segmented and analyzed for demand and supply by end-user into hospitals, homecare settings, ambulatory centers, wound care centers, and others. Out of which, the hospitals segment is projected to witness noteworthy growth over the forecast period. The growth of the segment can be accounted to the increasing patient flow in hospitals dealing with chronic wounds. Furthermore, there have been rising numbers of hospitals, followed by increasing numbers of surgeries, and patients across the globe that is further expected to drive the growth of the segment in the region. For instance, it is estimated that every year around 4.2 million patients in Europe suffer from chronic wounds, needing 25%-50% of intense hospital beds.
Product (Advanced Wound Dressings, Wound Care Devices, Active Therapy)
On the other hand, the global chronic wound care market is segmented and analyzed for demand and supply by product into advanced wound dressings, wound care devices, active therapy, and others. Out of these, the advanced wound dressings segment is expected to hold the largest market size over the forecast period. This can be attributed to its lower cost, and its capability to manage different types of wounds. Moreover, there has been an increase in the use of advanced wound dressings for sports, and burn related injuries, that is projected to expand the segment’s growth in the market.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
Product |
|
|
End-User |
|
APAC Market Statistics
The Asia Pacific region is anticipated to witness the fastest growth in the upcoming years, backed by the rising number of diabetic patients along with the rapidly increasing elderly population. Moreover, there has been a surge in healthcare expenditure that is further expected to boost the market’s growth in the region.
North American Market Forecast
The North America chronic wound care market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033. The growth of the market can be ascribed to the rising patient pool suffering from chronic wounds, the increasing geriatric population, the high prevalence of diabetic foot ulcers, growing healthcare expenditure, and the existence of adequate reimbursement policies in the region. For instance, in 2019, approximately 8 to 13 million people were affected by chronic wounds in the United States. Moreover, there has been a surge in the number of sports related injuries in countries such as the U.S., that is expected to drive the market’s growth in the region.
Smith & Nephew PLC has announced the efficiency of its GRAFIX Membrane which reduces diabetic foot ulcer recurrence by half as compared to other leading competitors.
Integra LifeSciences Corporation announced the positive clinical outcomes with its PriMatrix Dermal Repair Scaffold for the treatment of hard-to-heal diabetic foot ulcers (DFUs). This is the largest DFU RCT ever conducted. A per protocol analysis found that 60% of DFUs healed within 12 weeks when PriMatrix was used in conjunction with standard care (SOC), compared to 35% for DFUs that healed within 12 weeks when SOC was used.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?